2m 2m 2m 2m 2m 2m 2m
Lexicon Pharma (LXRX)
NASDAQ
$2.31+$0.004 (+0.17%)
Price as of Aug 03, 2026 7:29 AM EDT- $1.0BMarket Cap
- 115.89%1-Year Change
- BiotechnologyIndustry
Lexicon Pharma (LXRX)
$2.31+$0.004 (+0.17%)
LXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.31 | ||
Change | -$0.03 (-1.28%) | ||
Open | $2.32 | ||
High | $2.35 | ||
Low | $2.25 | ||
Previous Close | $2.34 | ||
Volume | 2,767,972 | ||
30-Day Average Volume | 2,700,258 | ||
1-Week Change | 0.87% | ||
1-Month Change | -3.75% | ||
1-Year Change | 115.89% | ||
3-Year Change | 14.93% | ||
5-Year Change | -34.75% | ||
Fundamentals | |||
Shares Outstanding | 444.2M | ||
Total Assets | $268.8M | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | $21.1M | ||
Net Income | -$1.0M | ||
Free Cash Flow | -$14.7M | ||
EBIT | -$1.0M | ||
EBITDA | -$933,000.00 | ||
Net Working Capital | $176.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -1,112 | ||
Enterprise Value/Revenue | 49 | ||
P/B | 5 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -70 | ||
Price/Operating Cash Flow | -70 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/21/2015 | ||
Earnings & Revenue